CSET’s Steph Batalis shared her expert analysis in an op-ed published by The National Interest. In her piece, she discusses how proposed federal research funding cuts threaten not only U.S. scientific progress but also the safety and security of biological research. These cuts would weaken the safeguards, oversight, and resources that protect both scientists and the public from accidents and biological threats.

This report examines lessons from the North Carolina Life Sciences Apprenticeship Consortium for pharmaceutical and biomanufacturing workforce development, and analyzes how apprenticeship programs help address workforce shortages in emerging tech fields. It offers a practical framework with important considerations for designing and launching programs, and serves as a resource for employers, regional leaders, and policymakers seeking to build a more resilient and technically skilled workforce.

Data Snapshots are informative descriptions and quick analyses that dig into CSET’s unique data resources. This three-part series introduces CSET’s patent clusters, which connect related patents through citations and text similarity.

CSET's Steph Batalis shared her expert analysis in an op-ed published by DefenseOne. In her piece, she highlights how the United States’ faltering response to the ongoing measles outbreak reveals serious vulnerabilities in the nation’s public health and biodefense infrastructure.

Jack Corrigan and Vikram Venkatram shared their expert analysis in an op-ed published by The National Interest. In their piece, they examine the political and legal controversy surrounding the Biden administration’s draft guidance on “march-in rights” under the Bayh-Dole Act, which could allow federal agencies to lower drug prices by reclaiming patents on taxpayer-funded inventions when they are not reasonably accessible to the public.

Opposing narratives around AI for biotechnology raise the question: how are biotech researchers actually using AI in published research? CSET’s Steph Batalis, Catherine Aiken, and James Dunham explored this question by leveraging CSET’s merged academic corpus, enriched publication metadata, and research clusters.

CSET's Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by The Bulletin of the Atomic Scientists. The article explores discusses the complexities and challenges of screening DNA synthesis orders to prevent misuse of potentially dangerous genetic sequences.

In response to the Office of Science and Technology Policy's request for input on an AI Action Plan, CSET provides key recommendations for advancing AI research, ensuring U.S. competitiveness, and maximizing benefits while mitigating risks. Our response highlights policies to strengthen the AI workforce, secure technology from illicit transfers, and foster an open and competitive AI ecosystem.

Dr. Steph Batalis and Vikram Venkatram offered the following comment in response to the National Institute of Standards and Technology's request for information on safety considerations for chemical and biological AI models.

Artificial intelligence (AI) tools pose exciting possibilities to advance scientific, biomedical, and public health research. At the same time, these tools have raised concerns about their potential to contribute to biological threats, like those from pathogens and toxins. This report describes pathways that result in biological harm, with or without AI, and a range of governance tools and mitigation measures to address them.